Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| SPHK1 | Q9NYA1 | Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91) (Acetyltransferase SPHK1) (EC 2.3.1.-) | EnzymesMetabolic proteinsPredicted intracellular proteins | Arterial occlusive diseaseCirculatory system diseaseNasopharyngeal cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.28 | |||
| SPN1 | O95149 | Snurportin-1 (RNA U transporter 1) | Essential proteinsPredicted intracellular proteins | Limb-girdle muscular dystrophy | Other mediation | 1 | 0.28 | |||
| SPPL3 | Q8TCT6 | Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin homologous protein 1) (PSH1) (Presenilin-like protein 4) | EnzymesPredicted membrane proteins | 9 | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.28 | |||
| SPTCS | Q96JI7 | Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein) | Disease related genesHuman disease related genesPredicted intracellular proteins | Amyotrophic lateral sclerosisCharcot-Marie-Tooth diseaseHereditary spastic paraplegia | Fusion and delivery mediationImmune mediation | 1 | 0.28 | |||
| SPTN2 | O15020 | Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein) | Disease related genesHuman disease related genesPlasma proteins | Spinocerebellar ataxia | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.28 | |||
| SPXN4 | Q5MJ08 | Sperm protein associated with the nucleus on the X chromosome N4 (Nuclear-associated protein SPAN-Xn4) (SPANX-N4) (SPANX family member N4) | Predicted intracellular proteins | Other mediation | 1 | 0.28 | ||||
| SR5A3 | Q9H8P0 | Polyprenal reductase (EC 1.3.1.94) (3-oxo-5-alpha-steroid 4-dehydrogenase 3) (EC 1.3.1.22) (Steroid 5-alpha-reductase 2-like) (Steroid 5-alpha-reductase 3) (S5AR 3) (SR type 3) | Disease related genesEnzymesHuman disease related genes | 6 | CataractCongenital disorder of glycosylationIntellectual disability | Clinical-translation mediationMetabolism mediation | 1 | 0.28 | ||
| SRC | P12931 | Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src) | Cancer-related genesDisease related genesEnzymes | Acute myeloid leukaemiaBCR-ABL1-negative chronic myeloid leukaemiaBrain cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.28 | |||
| SSH1 | Q8WYL5 | Protein phosphatase Slingshot homolog 1 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 1) (SSH-1L) (hSSH-1L) | EnzymesPredicted intracellular proteins | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.28 | ||||
| SSR5 | P35346 | Somatostatin receptor type 5 (SS-5-R) (SS5-R) (SS5R) (SST5) | 7 | Alzheimer diseaseCushing syndromeStomach cancer | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.28 |